Natalizumab Treatment Modulates Peroxisome Proliferator-Activated Receptors Expression in Women with Multiple Sclerosis

Peroxisome Proliferator-Activated Receptors (PPAR) are transcription factors suggested to be involved in inflammatory lesions of autoimmune encephalomyelitis and multiple sclerosis (MS). Our objective was to assess whether Natalizumab (NTZ) therapy is associated with alterations of PPAR expression i...

Full description

Saved in:
Bibliographic Details
Published in:PPAR Res
Main Authors: Ferret-Sena, Véronique, Maia e Silva, Alexandra, Sena, Armando, Cavaleiro, Inês, Vale, José, Derudas, Bruno, Chinetti-Gbaguidi, Giulia, Staels, Bart
Format: Artigo
Language:Inglês
Published: Hindawi Publishing Corporation 2016
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5203914/
https://ncbi.nlm.nih.gov/pubmed/28077943
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/5716415
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items